Language

News topic

Expected end: 2026-07

All current shortage notices related to Expected end: 2026-07, structured by product, country, active ingredient and reporting period.

15 notices

← All shortages

Belgium

Epipen 300 µg inj. opl. i.m. voorgev. pen 2 ml

Active ingredient: Epinephrine

View notice details →
Belgium

Visipaque 320 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 200 ml

Active ingredient: Iodixanol

View notice details →
Belgium

Visipaque 270 mg I/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 50 ml

Active ingredient: Iodixanol

View notice details →
Belgium

Trinordiol omh. tabl. 3 x 21 (6 + 5 + 10)

Active ingredient: Levonorgestrel; Ethinylestradiol; Levonorgestrel; Ethinylestradiol; Levonorgestrel; Ethinylestradiol

View notice details →
Belgium

Sevikar 20 mg - 5 mg filmomh. tabl. 98

Active ingredient: Olmesartan Medoxomil; Amlodipine

View notice details →
Belgium

Quetiapine Viatris 25 mg filmomh. tabl. 250

Active ingredient: Quetiapine

View notice details →
Belgium

Quetiapine Krka 100 mg filmomh. tabl. 30

Active ingredient: Quetiapine

View notice details →
Belgium

Omnipaque 240 mg I/ml inj. opl. i.thec./i.v./i.arter. flac. 10 ml

Active ingredient: Iohexol

View notice details →
Belgium

Myozyme 50 mg inf. opl. (pdr., conc.) i.v. flac. 50 mg

Active ingredient: Alglucosidase Alfa

View notice details →
Belgium

Iomeron 350 mg/ml inj. opl. i.thec./i.cavern./i.v./i.arter. flac. 500 ml

Active ingredient: Iodine

View notice details →
Belgium

Clariscan 0.5 mmol/ml inj. opl. i.v. flac. 100 ml

Active ingredient: Tetraxetan; Gadolinium Oxide; Gadoteric Acid

View notice details →
Belgium

Alluzience 200 Speywood-Eenheden/ml inj. opl. i.m. flac. 2 x 0.625 ml

Active ingredient: Clostridium Botulinum Toxin Type A

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.